Sunday, October, 25, 2009
Asmanex
October 03, 2008
The U.S. Food and Drug Administration has approved the Asmanex
Twisthaler for once-daily use in young asthmatics. A higher dosage
strength of the medication is already approved for children ages 12
and older. The new approval means the med can be prescribed to
children ages 4 through 11.
Read more »
Expert & Community Posts
By James Thompson, MD
,
Health Expert
...members of ICS include: Flovent, Pulmicort, Qvar, Asmanex, Azmacort and Aerobid. Alvesco (like...
Read more »
By Kathi MacNaughton
,
Health Expert
...pharmaceutical company that makes the asthma medicine, Asmanex. If you order it now, you can...
Read more »
Health Guide
...it gets lost); medicines; steroid nasal spray (such as Nasonex); steroid inhaler (such as Flovent or
Asmanex); antihistamines (such as Claritin or Zyrtec); eye drops; eczema cream; hypoallergenic...
Read more »
...beta2-agonist in a single inhaler.The FDA approved a new inhaled corticosteroid, mometasone furoate (
Asmanex) in 2005.The older corticosteroid inhalants are beclomethasone (Beclovent, Vanceril)...
Read more »
...nebulizerFlunisolideAeroBidInhalerFluticasoneFloventInhalerFluticasone / SalmeterolAdvairInhalerMometasone
AsmanexInhalerTriamcinoloneAzmacortInhalerLong-Acting...
Read more »
...approved for children in this age group.The FDA approved a new inhaled corticosteroid, mometasone furoate (
Asmanex) was approved in 2005 for patients age 12 and older.The older corticosteroid...
Read more »
Medications
When used regularly, mometasone helps to prevent the wheezing and shortness of breath that can... Read more »
When used regularly, mometasone helps to prevent the wheezing and shortness of breath that can... Read more »
When used regularly, mometasone helps to prevent the wheezing and shortness of breath that can... Read more »
When used regularly, mometasone helps to prevent the wheezing and shortness of breath that can... Read more »
When used regularly, mometasone helps to prevent the wheezing and shortness of breath that can... Read more »
Related News
August 07, 2009
Drugmakers Novartis and Schering-Plough Corp. have announced they will collaborate on a new combination drug to treat asthma and chronic obstructive...
Read summary »